Search Results

You are looking at 1 - 1 of 1 items for :

  • Author: Irene Barrientos-Ruiz x
Clear All Modify Search
Joaquim Soares do Brito Orthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal

Search for other papers by Joaquim Soares do Brito in
Google Scholar
PubMed
Close
,
André Spranger Orthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal

Search for other papers by André Spranger in
Google Scholar
PubMed
Close
,
Paulo Almeida Orthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal

Search for other papers by Paulo Almeida in
Google Scholar
PubMed
Close
,
José Portela Orthopedics Department, University Hospital of Santa Maria, Lisbon, Portugal

Search for other papers by José Portela in
Google Scholar
PubMed
Close
, and
Irene Barrientos-Ruiz Orthopedics Department, University Hospital of La Paz, Madrid

Search for other papers by Irene Barrientos-Ruiz in
Google Scholar
PubMed
Close

  • Giant cell tumour of bone (GCT) is a relatively rare, locally aggressive benign neoplasm observed in the long bone epiphyseal-metaphyseal regions of young adults.

  • The optimal treatment strategy for these tumours remains controversial, and a huge amount of contradictory data regarding the functional and oncological outcomes can be found. Therefore, we performed a systematic review intended to investigate the functional and oncological outcomes after surgical treatment of GCTs arising around the knee, namely in the distal femur and proximal tibia.

  • A trend towards better oncological control was found using wide resections, nonetheless, curettage-based techniques achieve a highly acceptable recurrence rate with overall better knee function. A slight advantage favouring proximal tibia GCTs regarding the Musculoskeletal Tumor Society (MSTS) score was also observed.

  • Prospective studies comparing groups of more homogeneous patients, tumours, and treatment options should be developed to obtain more conclusive and definitive results regarding the optimal strategy for treating GCTs.

Cite this article: EFORT Open Rev 2021;6:641-650. DOI: 10.1302/2058-5241.6.200154

Open access